SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 300 filers reported holding SEATTLE GENETICS INC in Q4 2017. The put-call ratio across all filers is 0.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $5,778,000 | -42.1% | 108,000 | -41.1% | 0.31% | -42.1% |
| Q3 2017 | $9,984,000 | +38.7% | 183,500 | +31.9% | 0.54% | +20.5% |
| Q2 2017 | $7,197,000 | +119.4% | 139,100 | +166.5% | 0.44% | +114.5% |
| Q1 2017 | $3,281,000 | +19.1% | 52,200 | 0.0% | 0.21% | -8.4% |
| Q4 2016 | $2,754,000 | -50.4% | 52,200 | -49.3% | 0.23% | -49.8% |
| Q3 2016 | $5,557,000 | +33.6% | 102,900 | 0.0% | 0.45% | +15.7% |
| Q2 2016 | $4,158,000 | +269.3% | 102,900 | +220.6% | 0.39% | +241.2% |
| Q1 2016 | $1,126,000 | +98.9% | 32,100 | +126.1% | 0.11% | +16.3% |
| Q4 2013 | $566,000 | – | 14,200 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
| Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
| Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
| Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
| Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
| Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
| SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
| Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
| Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |